DE

Christian Eibl

This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christian Eibl. Retrieved from https://idiyas.com/inventor/christian-eibl-b2u33jcc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Christian Eibl: Innovator in Plant Biotechnology

Introduction

Christian Eibl is a notable inventor in the field of plant biotechnology. He has contributed to the advancement of genetic engineering, particularly in the area of plastid transformation. His innovative work focuses on creating transgenic plants that are devoid of selection markers, which is a significant step forward in the field.

Latest Patents

Christian Eibl holds a patent titled "Gene Expression In Plastids Based On Replicating Vectors." This patent describes a process for generating transgenic plants or plant cells transformed on their plastome. The process involves several steps, including transforming plastids with specific DNA sequences, allowing integration into the plastome under selective pressure, and subsequently recovering genetically transformed cells or plants without the selection marker.

Career Highlights

Throughout his career, Christian Eibl has worked with various companies, including Icon Genetics AG and Hans-Ulrich Koop. His experience in these organizations has allowed him to develop and refine his expertise in genetic transformation techniques.

Collaborations

Christian has collaborated with professionals in his field, including his coworker Stefan Muehlbauer. These collaborations have contributed to the advancement of research in plant biotechnology.

Conclusion

Christian Eibl's contributions to the field of plant biotechnology, particularly through his innovative patent, highlight his role as a significant inventor. His work continues to influence the development of transgenic plants and the future of genetic engineering.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…